ask="2.950"
ask_size="700"
average_daily_volume="28600"
bid="1.750"
bid_size="500"
book_value="2.844"
change="+0.275"
change_from_200_day_moving_average="-1.543"
change_from_50_day_moving_average="-0.654"
change_from_52_week_high="-3.755"
change_From_52_week_low="0.675"
change_in_percent="+11.458%"
close="2.675"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.037"
ebitda="-37.85M"
eps_estimate_current_year="-1.860"
eps_estimate_next_quarter="-0.300"
eps_estimate_next_year="-1.190"
ex_dividend_date="N/A"
float_shares="14251000"
high="2.750"
high_52_weeks="6.430"
last_trade_date="1/11/2017"
last_trade_price="2.675"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.500"
low_52_weeks="2.000"
market_capitalization="56.72M"
moving_average_200_day="4.218"
moving_average_50_day="3.329"
name="Strongbridge Biopharma plc - Or"
notes="N/A"
one_year_target_price="13.330"
open="2.600"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-36.588%"
percent_change_from_50_day_moving_average="-19.646%"
percent_change_from_52_week_high="-58.398%"
percent_change_from_52_week_low="+33.750%"
previous_close="2.400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.844"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="3.110"
stock_exchange="NMS"
symbol="SBBP"
volume="90583"
weeks_range_52="2.000 - 6.430"
